Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.1.01887
European Journal of Endocrinology, Vol 152, Issue 4, 575-580
Copyright © 2005 by European Society of Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haijma, S. V
Right arrow Articles by Koppeschaar, H. P F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haijma, S. V
Right arrow Articles by Koppeschaar, H. P F

CLINICAL STUDY

The GHRH/GHRP-6 test for the diagnosis of GH deficiency in elderly or severely obese men

Sander V Haijma1, P Sytze van Dam1,2, Wouter R de Vries3, Inge Maitimu-Smeele4, Carlos Dieguez5, Felipe F Casanueva3 and Hans P F Koppeschaar1

1 Department of Clinical Endocrinology, University Medical Centre, Utrecht, 2 Department of Internal Medicine, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands, 3 Department of Sports Medicine, 4 Laboratory for Endocrinology, University Medical Centre, Utrecht, The Netherlands and 5 Department of Medical Physiology, University of Santiago de Compostela, Santiago de Compostela, Spain

(Correspondence should be addressed to P Sytze van Dam, Department of Internal Medicine, Onze Lieve Vrouwe Gasthuis, PO Box 95 500, 1090HM Amsterdam, The Netherlands; Email: p.s.vandam{at}olvg.nl)

Objective and design: Ageing and obesity result in decreased activity of the GH/IGF-I axis and concomitant impaired GH responses to secretory stimuli. We therefore determined the validity of the GH cut-off value of 15.0 µg/l in the GH-releasing hormone (GHRH)/GH releasing peptide-6 (GHRP-6) test for the diagnosis of GH deficiency in elderly or severely obese men.

Methods: We performed a combined GHRH/GHRP-6 test in ten elderly men (mean age 74 years; mean body mass index (BMI) 24.6 kg/m2), nine obese men (mean age 47 years; mean BMI 40.6 kg/m2) and seven healthy male controls (mean age 51 years, mean BMI 24.3 kg/m2). After assessment of fasting plasma GH, IGF-I and IGF-binding protein-3 (IGFBP-3), GHRH (100 µg) and GHRP-6 (93 µg) were given intravenously as a bolus injection. Repeated GH measurements were performed for two hours. Results: Both peak GH levels and areas under the curve (AUC) were significantly lower in the obese than in the controls (peak 13.2 vs 53.4 µg/l, P = 0.001; AUC 707 vs 3250 µg/l x 120 min; P = 0.001). Mean GH response in the elderly was lower than in the controls (peak 35.0 µg/l; AUC 2274 µg/l x 120 min), but this was not statistically significant. In contrast, GH peak levels in seven obese men remained below the cut-off level of 15.0 µg/l associated with severe GH deficiency. All others had GH peak levels exceeding this threshold. IGFBP-3 levels were significantly lower in the elderly than in the controls (1.35 vs 2.05 mg/l, P = 0.001). Baseline GH or IGF-I did not differ significantly between groups.

Conclusions: GH responses following GHRH/GHRP-6 administration were significantly reduced in severely obese men, but were not significantly reduced in elderly men, despite a negative trend. Our data indicate that the cut-off GH level of 15.0 µg/l after GHRH + GHRP-6 administration for the diagnosis of severe GH deficiency cannot be used in severely obese men.




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
K. Chihara, A. Shimatsu, N. Hizuka, T. Tanaka, Y. Seino, Y. Katofor, and the KP-102 Study Group
A simple diagnostic test using GH-releasing peptide-2 in adult GH deficiency
Eur. J. Endocrinol., July 1, 2007; 157(1): 19 - 27.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. D. Veldhuis, M. Cosma, D. Erickson, R. Paulo, K. Mielke, L. S. Farhy, and C. Y. Bowers
Tripartite Control of Growth Hormone Secretion in Women during Controlled Estradiol Repletion
J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2336 - 2345.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
R. M Luque, M. D Gahete, R. J Valentine, and R. D Kineman
Examination of the direct effects of metabolic factors on somatotrope function in a non-human primate model, Papio anubis.
J. Mol. Endocrinol., August 1, 2006; 37(1): 25 - 38.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. M. Luque and R. D. Kineman
Impact of Obesity on the Growth Hormone Axis: Evidence for a Direct Inhibitory Effect of Hyperinsulinemia on Pituitary Function
Endocrinology, June 1, 2006; 147(6): 2754 - 2763.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
B. E. Engstrom, P. Burman, C. Holdstock, M. Ohrvall, M. Sundbom, and F A. Karlsson
Effects of gastric bypass on the GH/IGF-I axis in severe obesity - and a comparison with GH deficiency
Eur. J. Endocrinol., January 1, 2006; 154(1): 53 - 59.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 European Society of Endocrinology.